You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 15, October 17, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Genetic Disorders
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Validity of Reported Genetic Risk Factors for Acute Coronary Syndrome

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Morgan and colleagues1 maintained that aside from the beta-fibrinogen gene FGB (P = .03), none of the other 85 gene variants previously associated with ACS could be replicated in their study. However, we note that the most significant association with a variant of thrombospondin 2 (THBS2) (P = .002) was overlooked despite replicating an association2-3 with respect to allele and magnitude.

While we agree with the main conclusion of the study that it is premature to be using these genetic markers in clinical care, we found the methodology and conclusions to be oversimplified. Not considering the THBS2 results a replication highlights a more crucial matter: the subjectivity in deciding what constitutes a replication. Should we consider minor alleles that have apparent protective effects as invalid? Similarly, should we discount genes for which the original variant does not produce a significant association, but . . . [Full Text of this Article]

Jeanette J. McCarthy, PhD
jeanette.mccarthy@duke.edu
Duke Institute for Genome Sciences & Policy
Duke University Medical Center
Durham, North Carolina

Eric J. Topol, MD
Scripps Translational Science Institute
La Jolla, California


RELATED LETTERS

Validity of Reported Genetic Risk Factors for Acute Coronary Syndrome
W. Gregory Feero, Teri A. Manolio, Alan E. Guttmacher, and Francis S. Collins
JAMA. 2007;298(15):1757.
EXTRACT | FULL TEXT  

Validity of Reported Genetic Risk Factors for Acute Coronary Syndrome
Murielle Bochud, Arnaud Chiolero, and Fred Paccaud
JAMA. 2007;298(15):1757-1758.
EXTRACT | FULL TEXT  

Validity of Reported Genetic Risk Factors for Acute Coronary Syndrome
William Y.S. Wang
JAMA. 2007;298(15):1758-1759.
EXTRACT | FULL TEXT  

Validity of Reported Genetic Risk Factors for Acute Coronary Syndrome—Reply
Thomas M. Morgan, Harlan M. Krumholz, Richard P. Lifton, and John A. Spertus
JAMA. 2007;298(15):1759.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Nonvalidation of Reported Genetic Risk Factors for Acute Coronary Syndrome in a Large-Scale Replication Study
Thomas M. Morgan, Harlan M. Krumholz, Richard P. Lifton, and John A. Spertus
JAMA. 2007;297(14):1551-1561.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.